Pacira | PCRX - 债务利息支出

金融业

USD

USD 1.21B

现金及等价物

USD 144.31M

USD 50.74M

USD 514.96M

USD 108.79M

USD 367.66M

USD 4.63M

USD 40.24M

790

EPS每股收益

USD 0.6

股本和储备

USD 653.89M

USD 126.64M

债务利息支出

USD 3.7M

USD 2.3M

USD 367.66M

USD 1.09B

USD 2.92M

USD 172.75M

USD 4.63M

普通股股本

USD 39.31M

38.58

USD 571K

USD 177M

销售和管理费用

USD 83.88M

USD 150.37M

贸易债权人

USD 14.01M

应收帐款人

USD 125.64M

	债务利息支出	更改		日
Assertio Holdings	USD 758K		1000	2024-06
Astellas Pharma	JPY 3.91B		320M	2025-03
Bristol-Myers Squibb	USD 411M		21M	2026-03
Cara Therapeutics	-89.64M		128.67M	2025-12
Coherus Biosciences	USD 2.25M		76K	2025-12
Heron Therapeutics	USD 600K		100K	2024-12
Ironwood Pharmaceuticals	USD 8.74M		506K	2024-12
J&J	USD 43M		25M	2026-03
Ligand Pharmaceuticals	USD 1.78M		875K	2025-12
Nektar Therapeutics	USD 9.77M		3.75M	2025-12
Novo Nordisk	DKK 1.53B		3.43B	2025-09
Omeros	USD 4.05M		5.16M	2024-09
Pacira	USD 3.7M		193K	2026-03
Perrigo	USD 7.98B		7.94B	2026-03
Pfizer	USD 671M		40M	2026-03
Supernus Pharmaceuticals	USD 910K		278K	2023-06
Teva Pharmaceutical Industries	USD 216M		4M	2026-03
Xeris Pharmaceuticals	USD 7.15M		115K	2025-12
Xoma	USD 3.4M		150K	2024-06
Zoetis	USD 62M		5M	2026-03